UA96573C2 - Антагонисты кинина для лечения дисфункции мочевого пузыря - Google Patents

Антагонисты кинина для лечения дисфункции мочевого пузыря

Info

Publication number
UA96573C2
UA96573C2 UAA200714809A UAA200714809A UA96573C2 UA 96573 C2 UA96573 C2 UA 96573C2 UA A200714809 A UAA200714809 A UA A200714809A UA A200714809 A UAA200714809 A UA A200714809A UA 96573 C2 UA96573 C2 UA 96573C2
Authority
UA
Ukraine
Prior art keywords
bladder dysfunction
treating bladder
kinin antagonists
kinin
antagonists
Prior art date
Application number
UAA200714809A
Other languages
English (en)
Ukrainian (uk)
Inventor
Кристоф ГИБСОН
Герд ХУММЕЛЬ
Йохен Кнолле
Ульрих РАЙНЕКЕ
Томас ТРАДЛЕР
Original Assignee
Ерини Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ерини Аг filed Critical Ерини Аг
Publication of UA96573C2 publication Critical patent/UA96573C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Данное изобретение касается применения антагониста рецептора кинина для производства медикамента для лечения и/или профилактики дисфункции мочевого пузыря, где рецептор кинина выбран из группы, которая включает рецепторы В1 и В2.
UAA200714809A 2005-07-05 2006-07-04 Антагонисты кинина для лечения дисфункции мочевого пузыря UA96573C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05014581A EP1741444A1 (en) 2005-07-05 2005-07-05 Kinin antagonists for treating bladder dysfunction

Publications (1)

Publication Number Publication Date
UA96573C2 true UA96573C2 (ru) 2011-11-25

Family

ID=34937780

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200714809A UA96573C2 (ru) 2005-07-05 2006-07-04 Антагонисты кинина для лечения дисфункции мочевого пузыря

Country Status (17)

Country Link
US (1) US20080221039A1 (ru)
EP (2) EP1741444A1 (ru)
JP (1) JP2009500362A (ru)
KR (1) KR20080025120A (ru)
CN (1) CN101212985A (ru)
AR (1) AR054820A1 (ru)
AT (1) ATE521365T1 (ru)
AU (1) AU2006265266A1 (ru)
BR (1) BRPI0613724A2 (ru)
CA (1) CA2613627A1 (ru)
IL (1) IL188316A0 (ru)
RU (1) RU2008104134A (ru)
SG (1) SG163564A1 (ru)
TW (1) TW200800249A (ru)
UA (1) UA96573C2 (ru)
WO (1) WO2007003411A2 (ru)
ZA (1) ZA200711240B (ru)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
DE102005013967A1 (de) * 2004-11-05 2006-10-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Bradykinin-B1-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽ｂ２受體調節劑
FR2919803B1 (fr) * 2007-08-07 2011-07-22 Sanofi Aventis Utilisation d'un antagoniste non peptidique du recepteur b1 pour la preparation de medicaments utiles pour le traitement de l'obesite et des pathologies liees a l'obesite ou au diabete
JP2011512329A (ja) * 2008-02-06 2011-04-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 有効な鎮痛剤としてのアリールスルホンアミド
IT1391236B1 (it) * 2008-07-11 2011-12-01 St Luso Farm D'italia Spa Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso
US9415048B2 (en) 2010-07-08 2016-08-16 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US20130323288A1 (en) 2010-07-08 2013-12-05 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
AU2012363788B2 (en) 2012-01-04 2017-03-09 Wellesley Pharmaceuticals, Llc Delayed-release formulation for reducing the frequency of urination and method of use thereof
US10278925B2 (en) 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
AU2013293488B2 (en) * 2012-07-27 2018-05-17 David A. Dill Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US10792326B2 (en) 2013-06-28 2020-10-06 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
WO2015017575A2 (en) 2013-08-01 2015-02-05 Dignify Therapeutics, Inc. Compositions and methods for inducing urinary voiding and defecation
CN103588861B (zh) * 2013-10-25 2015-11-04 中国药科大学 新德里金属β-内酰胺酶的抑制肽及其应用
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
MX2020005287A (es) 2017-11-24 2020-08-13 Pharvaris Netherlands B V Antagonistas novedosos del receptor b2 de bradiquinina.
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9505491D0 (en) * 1995-03-18 1995-05-03 Merck Sharp & Dohme Therapeutic agents
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
PL365694A1 (en) * 2000-06-28 2005-01-10 Teva Pharmaceutical Industries Ltd. Carvedilol
FR2822827B1 (fr) * 2001-03-28 2003-05-16 Sanofi Synthelabo Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant
US7063860B2 (en) * 2001-08-13 2006-06-20 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
EP1476419B1 (en) * 2002-02-08 2006-02-01 Merck & Co., Inc. N-biphenylmethyl aminocycloalkanecarboxamide derivatives
US20040044041A1 (en) * 2002-08-06 2004-03-04 Kuduk Scott D. 2-(Biarylalkyl)amino-3-(cyanoalkanoylamino)pyridine derivatives
EP1589959A2 (en) * 2003-01-30 2005-11-02 Dynogen Pharmaceuticals Inc. Methods of treating lower urinary tract disorders using sodium channel modulators
ES2398460T3 (es) * 2003-02-06 2013-03-19 Queen's University Of Belfast Péptido antagonista del receptor B2 de bradiquinina proveniente de la piel de un anfibio
DE602004003172T2 (de) * 2003-03-21 2007-09-27 Dynogen Pharmaceuticals Inc., Waltham Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals

Also Published As

Publication number Publication date
CN101212985A (zh) 2008-07-02
US20080221039A1 (en) 2008-09-11
AR054820A1 (es) 2007-07-18
EP1741444A1 (en) 2007-01-10
CA2613627A1 (en) 2007-01-11
ATE521365T1 (de) 2011-09-15
EP1901775B1 (en) 2011-08-24
WO2007003411A3 (en) 2007-05-18
WO2007003411A2 (en) 2007-01-11
JP2009500362A (ja) 2009-01-08
RU2008104134A (ru) 2009-08-10
KR20080025120A (ko) 2008-03-19
TW200800249A (en) 2008-01-01
ZA200711240B (en) 2008-08-27
SG163564A1 (en) 2010-08-30
EP1901775A2 (en) 2008-03-26
AU2006265266A1 (en) 2007-01-11
IL188316A0 (en) 2008-04-13
BRPI0613724A2 (pt) 2011-02-08

Similar Documents

Publication Publication Date Title
SG163564A1 (en) Kinin antagonists for treating bladder dysfunction
WO2008008517A3 (en) Bridged diazepan orexin receptor antagonists
PL2049529T3 (pl) Podstawione związki diazepanowe - antagoniści receptora oreksyny
WO2005072308A3 (en) Cgrp receptor antagonists
WO2007126935A3 (en) Diazepan orexin receptor antagonists
MY161834A (en) Substituted diazepan compounds as orexin receptor antagonists
GEP20115140B (en) Substituted spirocyclic cgrp receptor antagonists
WO2007126934A3 (en) Amidoethylthioether orexin receptor antagonists
IL182317A0 (en) Cgrp receptor antagonists
EA201100133A1 (ru) Антагонисты рецепторов простагландина d
TN2011000171A1 (en) Isonicotinamide orexin receptor antagonists
ATE469895T1 (de) Cgrp-rezeptorantagonisten
MX2009005363A (es) Pirimidinas y su uso como antagonistas del receptor cxcr2.
UA100974C2 (ru) Соединения замещенных диазепанов как антагонисты орексиновых рецепторов
WO2006047196A3 (en) Cgrp receptor antagonists
WO2007016087A3 (en) Heterocyclic benzodiazepine cgrp receptor antagonists
WO2007108936A3 (en) N-substituted-azacyclylamines as histamine-3 antagonists
EP1861399A4 (en) CGRP RECEPTOR ANTAGONISTS
NO20085051L (no) Behandling av gastrointestinale forstyrrelser med CGRP-antagonister
WO2007136668A3 (en) N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
WO2008045371A3 (en) N-substituted-azacyclylamines as histamine-3 antagonists
EP1802372A4 (en) CGRP RECEPTOR ANTAGONISTS)
PL2001456T3 (pl) Zastosowanie kompozycji zawierających antagonistę receptora opioidowego kappa do leczenia zaburzeń dysocjacyjnych
PL2201002T3 (pl) Antagoniści receptora 5-HT7
WO2006106358A3 (en) Use of nk-3 receptor antagonists for the treatment of nausea and vomiting